GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » ROA %

Aarti Pharmalabs (BOM:543748) ROA % : 10.11% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Aarti Pharmalabs's annualized Net Income for the quarter that ended in Mar. 2024 was ₹2,610 Mil. Aarti Pharmalabs's average Total Assets over the quarter that ended in Mar. 2024 was ₹25,821 Mil. Therefore, Aarti Pharmalabs's annualized ROA % for the quarter that ended in Mar. 2024 was 10.11%.

The historical rank and industry rank for Aarti Pharmalabs's ROA % or its related term are showing as below:

BOM:543748' s ROA % Range Over the Past 10 Years
Min: -1.84   Med: 9.04   Max: 11.98
Current: 9.13

During the past 4 years, Aarti Pharmalabs's highest ROA % was 11.98%. The lowest was -1.84%. And the median was 9.04%.

BOM:543748's ROA % is ranked better than
82.35% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.61 vs BOM:543748: 9.13

Aarti Pharmalabs ROA % Historical Data

The historical data trend for Aarti Pharmalabs's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs ROA % Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
ROA %
-1.84 11.98 9.06 9.01

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.66 8.44 8.96 9.12 10.11

Competitive Comparison of Aarti Pharmalabs's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's ROA % distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's ROA % falls into.



Aarti Pharmalabs ROA % Calculation

Aarti Pharmalabs's annualized ROA % for the fiscal year that ended in Mar. 2024 is calculated as:

ROA %=Net Income (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=2169/( (22309.272+25821)/ 2 )
=2169/24065.136
=9.01 %

Aarti Pharmalabs's annualized ROA % for the quarter that ended in Mar. 2024 is calculated as:

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2610/( (0+25821)/ 1 )
=2610/25821
=10.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data. ROA % is displayed in the 30-year financial page.


Aarti Pharmalabs  (BOM:543748) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=2610/25821
=(Net Income / Revenue)*(Revenue / Total Assets)
=(2610 / 20230.8)*(20230.8 / 25821)
=Net Margin %*Asset Turnover
=12.9 %*0.7835
=10.11 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Aarti Pharmalabs ROA % Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs (BOM:543748) Business Description

Traded in Other Exchanges
Address
204, Udyog Kshetra, Mulund Goregaon Link Road, 2nd floor,, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives.

Aarti Pharmalabs (BOM:543748) Headlines

No Headlines